TREACE MED CONCEPTS INC shareholders Q3 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

TREACE MED CONCEPTS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Candriam S.C.A. 427,972$5,610,7130.04%
Jump Financial, LLC 67,490$884,7940.03%
Y-Intercept (Hong Kong) Ltd 25,464$333,8330.03%
Ghisallo Capital Management LLC 25,000$327,7500.03%
PRELUDE CAPITAL MANAGEMENT, LLC 36,000$471,9600.03%
VisionPoint Advisory Group, LLC 5,347$70,0990.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 271,981$3,565,6710.03%
LOOMIS SAYLES & CO L P 1,126,583$14,7690.02%
ALLIANCEBERNSTEIN L.P. 4,308,842$56,488,9190.02%
XTX Topco Ltd 10,174$133,3810.02%
Newbridge Financial Services Group, Inc. 3,556$46,6190.02%
TUDOR INVESTMENT CORP ET AL 142,530$1,868,5680.02%
Dakota Wealth Management 30,665$402,0220.02%
Aquatic Capital Management LLC 29,200$3830.02%
GABELLI FUNDS LLC 141,252$1,851,8140.02%
RiverPark Advisors, LLC 1,188$15,5750.01%
Alyeska Investment Group, L.P. 149,366$1,958,1880.01%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 250,026$3,277,8410.01%
Allspring Global Investments Holdings, LLC 391,079$5,127,0450.01%
Connor, Clark & Lunn Investment Management Ltd. 90,968$1,192,5900.01%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q3 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.